Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome

OBJECTIVE-Dysregulated apolipoprotein (apo)C-III metabolism may account for hypertriglyceridemia and increased cardiovascular risk in the metabolic syndrome. This study investigated the dose-dependent effect of rosuvastatin on VLDL apoC-1II transport in men with the metabolic syndrome.RESEARCH DESIG...

Full description

Bibliographic Details
Main Authors: Ooi, E., Watts, G., Chan, D., Chen, Meifania, Nestel, P., Sviridov, D., Barrett, H.
Format: Journal Article
Published: American Diabetes Association ADA 2008
Online Access:http://hdl.handle.net/20.500.11937/32130

Internet

http://hdl.handle.net/20.500.11937/32130

Similar Items